/Biotech
Rapid Detection of Genetic Markers for Rare Disease Diagnostics
Problem
Early assay sensitivity and specificity fell short for clinical use and submission.
Approach
Sensitivity/specificity validation with clinical-applicability assessment and stability testing.
Partner
A genomics startup (placeholder)
Field
Biotech
Service
Clinical & Pharma Support
Result
¥1.3M
Annual cost savings for early adopters (placeholder)
With a genomics startup, we validated a reliable, low-cost assay for rare genetic disease markers.
The Challenge
The team developed an assay for rare genetic markers but lacked validation data on sensitivity, specificity and clinical applicability — blocking submission and commercialization.
Solution
We focused on method validation:
- Systematic sensitivity and specificity assessment
- Clinical sample applicability validation
- Stability and batch-to-batch consistency testing
- Structured reporting to support submission
Result
The validation data supported a successful funding round and delivered meaningful cost savings for early adopters.
This data moved us from 'a concept' to 'deployable'.
“Rigorous validation data helped us secure our next funding round smoothly.”
.png)